目的 运用孟德尔随机化(MR)的方法来探讨ω-3/6多不饱和脂肪酸(PUFA)与儿童肥胖的因果关联,以期为儿童肥胖的健康管理提供新的参考。方法 利用全基因组关联研究(GWAS)的数据,ω-3/6 PUFA等7种表型作为暴露因素,儿童肥胖为结局因素。采用逆方差加权法(IVW)、MR-Egger回归、简单模型、加权中位数、加权模型等5种方法进行两样本MR分析。结论主要参照IVW法,其他分析方法的仅作为结果稳健性的参考。并进行异质性、水平多效性、MR-PRESSO、留一法、Steiger检验等敏感性分析。结果 ω-3 PUFA(OR=0.82, 95%CI:0.71~0.96,P=0.012)、ω-3 PUFA与总脂肪酸比率(OR=0.83, 95%CI: 0.73~0.95, P=0.007)、二十二碳六烯酸(DHA)(OR=0.81, 95%CI: 0.69~0.95, P=0.011)与儿童肥胖呈负相关性,但ω-6/ω-3 PUFA比值与儿童肥胖呈正相关性(OR=1.18,95%CI: 1.04~1.34, P=0.013),未观察到ω-6 PUFA、ω-6 PUFA与总脂肪酸比率、亚油酸(PHA)与儿童肥胖存在显著的因果关联(P＞0.05)。在敏感性分析中,除亚油酸外的其余六组数据均通过了全部检验,表明结果具有良好的稳健性。结论 ω-3 PUFA、ω-3 PUFA与总脂肪酸的比率、DHA是儿童肥胖的保护因素;ω-6/ω-3 PUFA比值是儿童肥胖风险因素。在膳食中增加ω-3 PUFA的含量或平衡ω-3和ω-6 PUFA的摄入量可能有利于降低儿童发生肥胖风险。
Abstract
Objective To investigate the causal relationship between ω-3/6 polyunsaturated fatty acids (PUFAs) and childhood obesity using Mendelian randomization (MR), in order to provide new insights for the health management of childhood obesity. Methods Data from genome-wide association studies (GWAS) were utilized, with seven phenotypes, including ω-3/6 PUFAs, as exposure factors and childhood obesity as the outcome factor. Two-sample MR analysis was conducted using five methods: inverse-variance weighted (IVW), MR-Egger regression, simple mode, weighted median, and weighted mode. The primary conclusions were based on the IVW method, while other methods served as references for robustness. Sensitivity analyses, including heterogeneity, horizontal pleiotropy, MR-PRESSO, leave-one-out, and Steiger tests, were also performed. Results ω-3PUFAs (OR=0.82, 95% CI: 0.71 - 0.96, P=0.012), the ratio of ω-3 PUFAs to total fatty acids (OR=0.83, 95%CI: 0.73 - 0.95, P=0.007), and docosahexaenoic acid (DHA) (OR=0.81, 95%CI: 0.69 - 0.95, P=0.011)were negatively associated with childhood obesity. In contrast, the ω-6/ω-3 PUFA ratio showed a positive association with childhood obesity (OR=1.18, 95%CI: 1.04 - 1.34, P=0.013). No significant causal relationships were observed between ω-6 PUFAs, the ratio of ω-6 PUFAs to total fatty acids, linoleic acid, and childhood obesity (P>0.05). In sensitivity analysis, all six datasets, except for linoleic acid, passed all tests, demonstrating the robustness of the results. Conclusions ω-3 PUFAs, the ratio of ω-3 PUFAs to total fatty acids, and DHA are protective factors against childhood obesity, while the ω-6/ω-3 PUFA ratio is a risk factor. Increasing ω-3 PUFA intake or balancing the intake of ω-3 and ω-6 PUFAs in the diet may help reduce the risk of childhood obesity.
关键词
儿童肥胖 /
ω-3多不饱和脂肪酸 /
ω-6多不饱和脂肪酸 /
二十二碳六烯酸 /
孟德尔随机化
Key words
childhood obesity /
ω-3 polyunsaturated fatty acids /
ω-6 polyunsaturated fatty acids /
ocosahexaenoic acid /
Mendelian randomization
{{custom_sec.title}}
{{custom_sec.title}}
{{custom_sec.content}}
参考文献
[1] XF Pan, Wang L, Pan A. Epidemiology and determinants of obesity in China[J]. Lancet Diabetes Endocrinol, 2021, 9(6): 373-392.
[2] 席波.综合防控儿童肥胖遏制潜在健康危害[J].中国学校卫生,2024,45(10): 1369-1371,1377.
Xi B.Comprehensive prevention and management of childhood obesity to reduce potential adverse health outcome[J].Chin J Sch Health,2024,45(10): 1369-1371,1377.(in Chinese)
[3] 陈宜人,吴丽君,陈芳芳.脂质组学分析方法在儿童健康与疾病中的应用[J].中国儿童保健杂志,2023,31(10): 1091-1095.
Chen YR, WU LJ, Chen FF. Application of lipidomics analy-sis in children's health and diseases[J]. Chin J Child Health Care, 2023, 31(10): 1091-1095. (in Chinese)
[4] V Hainer, Toplak H, Mitrakou A. Treatment modalities of obesity:What fits whom[J]. Diabetes Care, 2008, 31(2): S269-S277.
[5] AM Chao, Quigley KM, Wadden TA. Dietary interventions for obesity: Clinical and mechanistic findings[J]. J Clin Invest, 2021, 131(1): e140065.
[6] G Fiore, Pascuzzi MC, Di Profio E, et al. Bioactive compounds in childhood obesity and associated metabolic complications: Current evidence, controversies and perspectives[J]. Pharmacol Res, 2023, 187: 106599.
[7] Lassandro C, Banderali G, Radaelli G, et al. Docosahexaenoic acid levels in blood and metabolic syndrome in obese children: Is there a link?[J]. Int J Mol Sci, 2015, 16(8): 19989-20000.
[8] Wang L, Manson JE, Rautiainen S, et al. A prospective study of erythrocyte polyunsaturated fatty acid, weight gain, and risk of becoming overweight or obese in middle-aged and older women[J]. Eur J Nutr, 2016, 55(2): 687-697.
[9] Africa JA, Newton KP, Schwimmer JB. Lifestyle interventions including nutrition, exercise, and supplements for nonalcoholic fatty liver disease in children[J]. Dig Dis Sci, 2016, 61(5): 1375-1386.
[10] Chen W, Ao Y, Lan X, et al. Associations of specific dietary unsaturated fatty acids with risk of overweight/obesity: Population-based cohort study[J]. Front Nutr, 2023, 10: 1150709.
[11] Jazayeri S, Heshmati J, Mokhtari Z, et al. Effect of omega-3 fatty acids supplementation on anthropometric indices in children and adolescents: A systematic review and meta-analysis of randomized controlled trials[J]. Complement Ther Med, 2020, 53: 102487.
[12] Huang Z, Ma K, Yin X, et al. The associations of fatty acids related dietary patterns with overweight and obesity among Chinese children[J]. J Health Popul Nutr, 2024, 43(1): 54.
[13] AP Simopoulos. An increase in the omega-6/omega-3 fatty acid ratio increases the risk for obesity[J]. Nutrients, 2016, 8(3): 128-145.
[14] Verduci E, Radaelli G, Salvioni M, et al. Plasma long-chain fatty acids profile and metabolic outcomes in normolipidaemic obese children after one-year nutritional intervention[J]. Acta Paediatr, 2011, 100(4): 585-589.
[15] Emdin CA, Khera AV, Kathiresan S. Mendelian randomization[J]. JAMA, 2017, 318(19): 1925-1926.
[16] Grover S. Mendelian randomization: Methods for using genetic variants in causal estimation [M]. London, UK: Chapman & Hall/CRC Press, 2015.
[17] Smith GD, Ebrahim S. 'Mendelian randomization': Can genetic epidemiology contribute to understanding environmental determinants of disease[J]. Int J Epidemiol, 2003, 32(1): 1-22.
[18] Skrivankova VW, Richmond RC, Woolf BAR, et al. Strengthening the reporting of observational studies in epidemiology using mendelian randomization: The STROBE-MR statement[J]. JAMA, 2021, 326(16): 1614-1621.
[19] Richardson TG, Leyden GM, Wang Q, et al. Characterising metabolomic signatures of lipid-modifying therapies through drug target mendelian randomisation[J]. PLoS Biol, 2022, 20(2): e3001547.
[20] Bradfield JP, Taal HR, Timpson NJ, et al. A genome-wide association meta-analysis identifies new childhood obesity loci[J]. Nat Genet, 2012, 44(5): 526-531.
[21] Hampl SE, Hassink SG, Skinner AC, et al. Clinical practice guideline for the evaluation and treatment of children and adolescents with obesity[J]. Pediatrics, 2023, 151(2): e2022060641.
[22] Sekula P, Del Greco MF, Pattaro C, et al. Mendelian randomization as an approach to assess causality using observational data[J]. J Am Soc Nephrol, 2016, 27(11): 3253-3265.
[23] Hartwig FP, Davies NM, Hemani G, et al. Two-sample Mendelian randomization: Avoiding the downsides of a powerful, widely applicable but potentially fallible technique[J]. Int J Epidemiol, 2016, 45(6): 1717-1726.
[24] Burgess S, Thompson SG. Bias in causal estimates from Mendelian randomization studies with weak instruments[J]. Stat Med, 2011, 30(11): 1312-1323.
[25] Slob EAW, Burgess S. A comparison of robust Mendelian randomization methods using summary data[J]. Genet Epidemiol, 2020, 44(4): 313-329.
[26] Burgess S, Dudbridge F, Thompson SG. Combining information on multiple instrumental variables in Mendelian randomization: Comparison of allele score and summarized data methods[J]. Stat Med, 2016, 35(11): 1880-1906.
[27] Selvaraju V, Venkatapoorna CMK, Babu JR, et al. Salivary amylase gene copy number is associated with the obesity and inflammatory markers in children[J]. Diabetes Metab Syndr Obes, 2020, 13: 1695-1701.
[28] Purdy JC, Shatzel JJ. The hematologic consequences of obesity[J]. Eur J Haematol, 2021, 106(3): 306-319.
[29] de Farias Fraga G, da Silva Rodrigues F, Jantsch J, et al. Omega-3 attenuates disrupted neurotransmission and partially protects metabolic dysfunction caused by obesity in wistar rats[J]. Neurochem Res, 2024, 49(10): 2763-2773.
[30] Albracht-Schulte K, Kalupahana NS, Ramalingam L, et al.Omega-3 fatty acids in obesity and metabolic syndrome: a mechanistic update[J]. J Nutr Biochem, 2018, 58: 1-16.
[31] Djuricic I, Calder PC. Beneficial outcomes of omega-6 and omega-3 polyunsaturated fatty acids on human health: An update for 2021[J]. Nutrients, 2021, 13(7): 2421.
[32] Zhang YY, Liu W, Zhao TY, et al. Efficacy of omega-3 polyunsaturated fatty acids supplementation in managing overweight and obesity: A Meta-analysis of randomized clinical trials[J]. J Nutr Health Aging, 2017, 21(2): 187-192.
[33] Gray B, Steyn F, Davies PS, et al. Omega-3 fatty acids: A review of the effects on adiponectin and leptin and potential implications for obesity management[J]. Eur J Clin Nutr, 2013, 67(12): 1234-1242.
[34] Lepretti M, Martucciello S, Burgos Aceves-MA, et al. Omega-3 fatty acids and insulin resistance: Focus on the regulation of mitochondria and endoplasmic reticulum stress[J]. Nutrients, 2018, 10(3): 350.
[35] HM O'Neill, Holloway GP, Steinberg GR. AMPK regulation of fatty acid metabolism and mitochondrial biogenesis: Implications for obesity[J]. Mol Cell Endocrinol, 2013, 366(2): 135-151.
[36] Santamarina AB, Mennitti LV, de Souza EA, et al. A low-carbohydrate diet with different fatty acids' sources in the treatment of obesity: Impact on insulin resistance and adipogenesis[J]. Clin Nutr, 2023, 42(12): 2381-2394.
[37] B Virgolici, Popescu LA, Virgolici HM, et al. Effects of omega-3 fatty acids associated with antioxidant vitamins in overweight and obese children[J]. Acta Endocrinol (Buchar), 2023, 19(2): 221-227.
[38] Kalupahana NS, Goonapienuwala BL, Moustaid-Moussa N. Omega-3 fatty acids and adipose tissue: Inflammation and browning[J]. Annu Rev Nutr, 2020, 40: 25-49.
[39] Saini RK, Keum YS. Omega-3 and omega-6 polyunsaturated fatty acids: Dietary sources, metabolism, and significance - A review[J]. Life Sci, 2018, 203: 255-267.
[40] Simopoulos AP. Dietary omega-3 fatty acid deficiency and high fructose intake in the development of metabolic syndrome, brain metabolic abnormalities, and non-alcoholic fatty liver disease[J]. Nutrients, 2013, 5(8): 2901-2923.
[41] Simopoulos AP. The importance of the ratio of omega-6/omega-3 essential fatty acids[J]. Biomed Pharmacother, 2002, 56(8): 365-379.
[42] Dyall SC, Balas L, Bazan NG, et al. Polyunsaturated fatty acids and fatty acid-derived lipid mediators: Recent advances in the understanding of their biosynthesis, structures, and functions[J]. Prog Lipid Res, 2022, 86: 101165.
[43] Das UN. Biological significance of essential fatty acids[J]. J Assoc Physicians India, 2006, 54: 309-319.
[44] Schwinkendorf DR, Tsatsos NG, Gosnell BA, et al. Effects of central administration of distinct fatty acids on hypothalamic neuropeptide expression and energy metabolism[J]. Int J Obes (Lond), 2011, 35(3): 336-344.
[45] Lepperdinger G. Inflammation and mesenchymal stem cell aging[J]. Curr Opin Immunol, 2011, 23(4): 518-524.
[46] Patterson E, Wall R, Fitzgerald GF, et al. Health implications of high dietary omega-6 polyunsaturated fatty acids[J]. J Nutr Metab, 2012, 2012: 539426.
[47] Vahdaninia M, Mackenzie H, Dean T, et al. The effectiveness of ω-3 polyunsaturated fatty acid interventions during pregnancy on obesity measures in the offspring: An up-to-date systematic review and meta-analysis[J]. Eur J Nutr, 2019, 58(7): 2597-2613.
[48] Rudolph MC, Young BE, Lemas DJ, et al. Early infant adipose deposition is positively associated with the n-6 to n-3 fatty acid ratio in human milk independent of maternal BMI[J]. Int J Obes (Lond), 2017, 41(4): 510-517.
[49] Simopoulos AP. The impact of the Bellagio Report on healthy agriculture, healthy nutrition, healthy people: Scientific and policy aspects and the international network of centers for genetics, nutrition and fitness for health[J]. J Nutrigenet Nutrigenomics, 2014, 7(4-6): 191-211.
[50] Mahmood L, Flores-Barrantes P, Moreno LA, et al. The influence of parental dietary behaviors and practices on children's eating habits[J]. Nutrients, 2021, 13(4): 1138.
[51] Bender N, Portmann M, Heg Z, et al. Fish or n3-PUFA intake and body composition:A systematic review and meta-analysis[J]. Obes Rev, 2014, 15(8): 657-665.
PDF(2682 KB)
